Financials Glory Health Industry Limited

Equities

2329

KYG394071040

Real Estate Development & Operations

Delayed Hong Kong S.E. 02:56:29 2024-04-29 am EDT 5-day change 1st Jan Change
0.039 HKD +25.81% Intraday chart for Glory Health Industry Limited +18.18% +21.88%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 8,622 7,766 6,474 2,880 1,105 1,021
Enterprise Value (EV) 1 37,067 34,647 33,138 24,757 21,493 22,082
P/E ratio 4.95 x 7.73 x 7.54 x 29.2 x 4.84 x -1.09 x
Yield 6.69% 2.83% 2.31% - - -
Capitalization / Revenue 1.27 x 1.17 x 0.8 x 0.5 x 0.11 x 0.26 x
EV / Revenue 5.46 x 5.24 x 4.09 x 4.29 x 2.17 x 5.66 x
EV / EBITDA 14 x 17.7 x 24.5 x 77.4 x 37 x -67.8 x
EV / FCF -5.75 x -56.7 x 15.9 x 3.61 x 16.3 x 241 x
FCF Yield -17.4% -1.76% 6.29% 27.7% 6.13% 0.42%
Price to Book 0.79 x 0.65 x 0.52 x 0.23 x 0.09 x 0.09 x
Nbr of stocks (in thousands) 4,442,818 4,444,418 4,444,418 4,444,418 4,444,418 4,444,418
Reference price 2 1.941 1.747 1.457 0.6481 0.2485 0.2296
Announcement Date 4/24/18 4/23/19 5/14/20 4/29/21 4/28/22 4/27/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 6,787 6,612 8,093 5,769 9,898 3,905
EBITDA 1 2,645 1,957 1,351 319.8 581.5 -325.9
EBIT 1 2,613 1,885 1,276 239.1 496 -415.1
Operating Margin 38.5% 28.5% 15.76% 4.14% 5.01% -10.63%
Earnings before Tax (EBT) 1 3,567 2,697 2,046 516.7 876.9 -1,090
Net income 1 1,750 1,009 859.8 98.74 228.3 -912.8
Net margin 25.78% 15.26% 10.62% 1.71% 2.31% -23.38%
EPS 2 0.3920 0.2260 0.1933 0.0222 0.0514 -0.2100
Free Cash Flow 1 -6,442 -611.2 2,083 6,864 1,318 91.71
FCF margin -94.92% -9.24% 25.74% 118.98% 13.32% 2.35%
FCF Conversion (EBITDA) - - 154.15% 2,146.36% 226.68% -
FCF Conversion (Net income) - - 242.32% 6,951.39% 577.35% -
Dividend per Share 2 0.1298 0.0495 0.0336 - - -
Announcement Date 4/24/18 4/23/19 5/14/20 4/29/21 4/28/22 4/27/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 28,445 26,881 26,664 21,877 20,389 21,062
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 10.75 x 13.74 x 19.73 x 68.41 x 35.06 x -64.62 x
Free Cash Flow 1 -6,442 -611 2,083 6,864 1,318 91.7
ROE (net income / shareholders' equity) 16.1% 9.99% 6.69% 0.79% 2.26% -6.68%
ROA (Net income/ Total Assets) 3.16% 1.76% 1.01% 0.2% 0.48% -0.44%
Assets 1 55,317 57,481 85,125 49,469 47,362 208,398
Book Value Per Share 2 2.450 2.680 2.820 2.810 2.860 2.640
Cash Flow per Share 2 0.3600 0.2300 0.1200 0.3600 0.1000 0.0300
Capex 1 477 437 129 273 280 193
Capex / Sales 7.02% 6.6% 1.6% 4.73% 2.82% 4.94%
Announcement Date 4/24/18 4/23/19 5/14/20 4/29/21 4/28/22 4/27/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2329 Stock
  4. Financials Glory Health Industry Limited